Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Diabetes may increase risk for developing Alzheimer’s and vascular dementia

Diabetes may increase risk for developing Alzheimer’s and vascular dementia

Sequester's budget cuts slowing Alzheimer's, other research

Sequester's budget cuts slowing Alzheimer's, other research

First Edition: June 10, 2013

First Edition: June 10, 2013

Scientists discover how Arc protein helps translate learning into memory

Scientists discover how Arc protein helps translate learning into memory

Large study of deep brain stimulation underway for Alzheimer's disease treatment

Large study of deep brain stimulation underway for Alzheimer's disease treatment

New noninvasive system allows people to control flying robot using only their mind

New noninvasive system allows people to control flying robot using only their mind

People with irregular heartbeat may be more likely to develop problems with memory, thinking

People with irregular heartbeat may be more likely to develop problems with memory, thinking

Surgeon develops new way to perform deep brain stimulation

Surgeon develops new way to perform deep brain stimulation

UCLA researchers identify abnormal brain networks in Fragile X syndrome

UCLA researchers identify abnormal brain networks in Fragile X syndrome

PCORI awards $2.1M to USF college of nursing to study a new approach for cancer management

PCORI awards $2.1M to USF college of nursing to study a new approach for cancer management

Tel Aviv University researchers find protein modification may help control Alzheimer's and epilepsy

Tel Aviv University researchers find protein modification may help control Alzheimer's and epilepsy

Assistive robotic technologies for people with dementia, other age-related disabilities

Assistive robotic technologies for people with dementia, other age-related disabilities

Researchers establish link between abnormal structure of synapses and behavioral abnormalities of brain circuits in FXS

Researchers establish link between abnormal structure of synapses and behavioral abnormalities of brain circuits in FXS

Study: Neural reserve, neural compensation activated in highly educated prodromal Alzheimer's patients

Study: Neural reserve, neural compensation activated in highly educated prodromal Alzheimer's patients

NeuroDerm receives MJFF grant to develop ND0612 for treatment of Parkinson's disease

NeuroDerm receives MJFF grant to develop ND0612 for treatment of Parkinson's disease

Elderly patients exposed to general anaesthesia face increased risk of developing dementia

Elderly patients exposed to general anaesthesia face increased risk of developing dementia

The more healthy lifestyle behaviors, the less memory issues

The more healthy lifestyle behaviors, the less memory issues

Scientists develop new chemical method to treat Alzheimer's disease

Scientists develop new chemical method to treat Alzheimer's disease

Mayo Clinic researchers envision new way to detect early onset of Alzheimer's disease

Mayo Clinic researchers envision new way to detect early onset of Alzheimer's disease

Researchers tie traumatic brain injury to toxic form of protein

Researchers tie traumatic brain injury to toxic form of protein

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.